![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 02, 2024 1:39:11 AM
If you are not reading the companies posts to X you are not up to date. They have apparently decided that is their marketing tool (I'm not thrilled about that, as it requires an account and it pretty crappy site now) and this is where their non quarterly updates are going. I shouldn't have to tell anyone this, but you can't only read the posts you have to read the replies. Do a little DD.
On 1/25 they posted they completed phase 1
Another update and another step that was taken during the fourth quarter #cancertherapy #newgenerationtherapy #genotoxicity #radiogel #isopet #innovations #cancer $RDGL pic.twitter.com/alvoqEDpXS
— Vivos Inc. (@VivosIncUSA) January 25, 2024
Then later that day clarified there were two phases
Two phases of testing, one phase of analysis, we are doing what is required and will update on the progress, stay tuned!
— Vivos Inc. (@VivosIncUSA) January 25, 2024
Follow the thread and you will see they never say when the second phase will occur despite being clearly asked. They just repeat the same story of we will keep you informed.
As I noted before, I believe they either don't know when they can get the second phase of testing done or they know it will take a long time and don't want to tell us.
It is most likely to be the former. Not just anyone can do genotoxicity testing. They have to find the experts that can do the testing and get on that companies calendar. Whatever the reason, taking the approach of avoiding giving an answer to a question any investor would want answered is stupid, diengienious, and detrimental to the investors interests.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM